Today: 19 May 2026
AppLovin stock price rises in midday trade as Needham turns bullish on Axon e-commerce push
28 January 2026
1 min read

AppLovin stock price rises in midday trade as Needham turns bullish on Axon e-commerce push

New York, January 28, 2026, 12:24 EST — Regular session

  • AppLovin shares ticked up roughly 1.2% in midday trading
  • Needham’s upgrade spotlighted Axon and the surge in e-commerce ad growth
  • Investors are eyeing the Feb. 11 results for a sharper picture of 2026

AppLovin shares climbed roughly 1.2% Wednesday, settling around $550.25 after hitting an intraday peak of $557.64.

This shift is significant as the ad-tech company’s shares have been volatile throughout the month, with investors still weighing the sustainability of its growth now that it’s expanding beyond mobile gaming ads.

New bullish research has added fuel to the debate. Traders are zeroing in on every datapoint that might reveal if AppLovin’s Axon advertising system is actually capturing more retail and direct-to-consumer budgets — or merely toying with them.

Needham & Company bumped the stock up to “buy” from “hold” and put a $700 price target on it, Barron’s reported. The upgrade comes as the firm noted progress in the company’s newer e-commerce advertising segment. Needham also raised its 2026 e-commerce revenue forecast to $1.45 billion and highlighted a growing roster of retail advertisers using Axon tools, naming Etsy and prediction-market platform Kalshi among them. Barron’s

In a separate note, Needham raised its expectations for advertiser growth, citing the self-service launch and increased spending as factors likely to “more than offset typical 1Q seasonality.” The firm also sees upside if the e-commerce expansion mirrors “a similar trajectory as TikTok.” Insider Monkey

Axon’s pitch is simple: leverage ad tools and measurement to pinpoint which campaigns actually boost sales, then ramp up spending. For investors, that’s the key variable — expanding the advertiser base could rapidly alter growth prospects, but it risks drying up if results falter.

The competitive bar is set high. E-commerce advertising budgets are largely dominated by established players like Alphabet’s Google, Meta, and Amazon, offering marketers numerous options if returns start to dip.

Still, risks linger. AppLovin remains under the microscope for its data practices. Reuters reported in October that the U.S. Securities and Exchange Commission is investigating its data-collection methods. At that time, a company spokesperson declined to comment on “any potential regulatory matters.” Reuters

Valuation remains a key pressure point. The stock’s volatility means even a slight slowdown in advertiser additions—or a tougher-than-expected first-quarter seasonal dip—can quickly weigh on the shares.

AppLovin will report its fourth-quarter and full-year 2025 earnings after the U.S. market closes on Feb. 11. CEO Adam Foroughi and CFO Matthew Stumpf will host a webcast at 5 p.m. ET to discuss the results.

Until then, investors are keeping an eye out for clear signs that Axon’s e-commerce efforts are driving steady spending, not just one-off trials — and any regulatory news that might shake up the trading range once more.

Stock Market Today

  • Yacktman Asset Management Cuts Alphabet Inc. Stake Amid Mixed Institutional Moves
    May 19, 2026, 2:13 PM EDT. Yacktman Asset Management LP reduced its stake in Alphabet Inc. (NASDAQ:GOOG) by 3.1% in Q4, selling 36,606 shares and holding 1,129,807 shares valued at $354.5 million, representing 5% of its portfolio. Other institutional investors showed varied activity with Brighton Jones LLC and Worldquant Millennium Advisors LLC increasing their holdings significantly. Alphabet's stock saw multiple analyst ratings, including 'outperform' and 'buy' with target prices ranging from $345 to $450, reflecting positive sentiment from firms like Scotiabank, TD Cowen, and Deutsche Bank. Institutional investors own 27.26% of Alphabet's shares. The stock remains a top focus amid ongoing trading by hedge funds and asset managers.

Latest articles

Why Recursion Stock Just Hit a 52-Week Low — and the FDA Update Traders Are Waiting For

Why Recursion Stock Just Hit a 52-Week Low — and the FDA Update Traders Are Waiting For

19 May 2026
Recursion Pharmaceuticals shares fell 2.2% to $2.825 Tuesday, hitting a 52-week low of $2.77, after reporting first-quarter revenue of $6.47 million, down from $14.75 million a year earlier. Net loss narrowed to $117.5 million. Early clinical data for REC-1245 showed no dose-limiting toxicities in 16 solid-tumor patients. The company ended March with $665.2 million in cash.
Wall Street’s Top Picks for U.S. Stocks as Yields Stay High

Wall Street’s Top Picks for U.S. Stocks as Yields Stay High

19 May 2026
U.S. stocks fell Tuesday as the 10-year Treasury yield reached its highest point since January 2025, pressuring growth shares. Nvidia drew the most attention ahead of its earnings, with options markets pricing in a possible $355 billion swing in value. Dell highlighted new AI infrastructure partnerships, while ServiceNow received a fresh Buy rating from Bank of America.
Nvidia’s Earnings Could Make or Break the AI Stock Trade

Nvidia’s Earnings Could Make or Break the AI Stock Trade

19 May 2026
Nvidia rose 0.8% ahead of its earnings report, while CoreWeave dropped 3.7% after Google and Blackstone announced a $5 billion U.S. AI cloud venture using Google’s custom TPUs. The new venture will offer 500 megawatts of data-center capacity by 2027. AMD and Micron also gained, but Microsoft and Broadcom slipped. Investors are watching whether Nvidia can maintain dominance as competition in AI inference intensifies.
AMAT stock pops on Mizuho upgrade as Applied Materials gets a $370 target
Previous Story

AMAT stock pops on Mizuho upgrade as Applied Materials gets a $370 target

Strategy Inc stock price slips as MSTR digests fresh bitcoin buy and a new Wall Street call
Next Story

Strategy Inc stock price slips as MSTR digests fresh bitcoin buy and a new Wall Street call

Go toTop